Mr. Zinn has co-founded several successful companies in the life sciences industry as CEO, COO and VPBD. While in academia, Don had leadership roles at Georgetown¹s HIV Research Facility (RIGHT), UMBC and the Uniformed Services University. Mr. Zinn is currently an Executive in Residence for the Apjohn Group and an Adjunct Professor at Grand Valley State University in the Department of Biological Sciences.
Ron has over 20 years experience in the pharmaceutical industry and served as the Director of Cardiovascular Therapeutics at Pharmacia & Upjohn from 1990-1998. Most recently, he served as the VP of Pre-Clinical Research for Afmedica, Inc, a Kalamazoo, MI-based biotech start-up that developed a drug-eluting (sirolimus) polymer product which was placed around surgical graft sites to prevent hemodialysis access and peripheral vascular graft failure. Afmedica was acquired by Angiotech Pharmaceuticals (Vancouver, B.C.) in late 2005.
Ron is an Adjunct Associate Professor of Pharmacology and Full Professor of Integrative Biology & Physiology at the University of Minnesota Medical School. He received his B.S. Degree in Microbiology from the University of Wisconsin in Madison (1976) and Ph.D. Degree in Pharmacology from the University of Minnesota Medical School in Minneapolis (1985).
Dan has worked successfully in both the pharmaceutical and medical device industries for large and small corporations for over 24 years. He began his career at Eli Lilly and Company in sales before holding positions of increased responsibility in marketing and managed care. Dan joined Diversified Pharmaceutical Services (a pharmacy benefit manager) as Senior Director of a new product development division focusing on formulary and patient compliance. Dan also led the business development and reimbursement areas for Equidyne, Inc and Upsher-Smith Laboratories before founding Strategic Pharmaceutical Solutions, Inc., which specializes in helping small companies buy or sell technology and develop reimbursement strategies. Dan holds a Bachelor of Science degree in pharmacy from Drake University.
Terry has 30 years financial experience in the pharmaceutical industry. Most recently he served as Finance Manager - Michigan Research Services for Pfizer, Inc. Prior to Pfizer he held financial director and manager roles for Pharmacia, Inc. information technology, royalty/licensing, facilities, cost accounting, and corporate systems organizations.
Dr. Seth Donahue is an Associate Professor in the Department of Biomedical Engineering at Michigan Technological University. He received his B.S. in mechanical engineering from Worcester Polytechnic Institute and his M.S. and Ph.D. in biomedical engineering from the University of California, Davis. He conducted a post-doctoral fellowship in cell biology in the Department of Orthopedics at the Pennsylvania State University Medical Center. He has published 21 journal papers and 40 conference proceedings in the areas of bone biology and mechanics. His research is supported by the National Institutes of Health, NASA, and the Whitaker Foundation. He is an active member of the American Society of Biomechanics, the Orthopedic Research Society, and the International Bone and Mineral Society.
